A Comparison of Vasodilating and Non-vasodilating Beta-Blockers and Their Effects on Cardiometabolic Risk-Reference-Cited by-同舟云学术

A Comparison of Vasodilating and Non-vasodilating Beta-Blockers and Their Effects on Cardiometabolic Risk

Published:2015-04-22 Issue:6 Volume:17 Page:
ISSN:1523-3782
Container-title:Current Cardiology Reports
language:en
Short-container-title:Curr Cardiol Rep

Author:

Fergus Icilma V.,Connell Kenneth L.,Ferdinand Keith C.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11886-015-0592-x.pdf

Reference41 articles.

1. Brunzell JD, Davidson M, Furberg CD, et al. Lipoprotein management in patients with cardiometabolic risk: Consensus Conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2008;51(15):1512–24. doi: 10.1016/j.jacc.2008.02.034 .

2. Lichtenstein H, Loria CM, Millen BE, Houston Miller N, Nonas CA, Eckel RH, et al. AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report. Circulation. 2013;2013:2–40.

3. Ayers K, Byrne LM, DeMatteo A, Brown NJ. Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome. Hypertension. 2012;59:893–8. This study describes the differences in metabolic and anti-inflammatory of a vasodilating (nebivolol) and non- vasodilating (metoprolol) drugs. It highlights the unique property of nebivolol as a vasodilating BB via NO mediated mechanisms.

4. Taylor AA, Bakris GL. The role of vasodilating beta-blockers in patients with hypertension and the cardiometabolic syndrome. Am J Med. 2010;123(7 Suppl 1):S21–6.

5. Fares H, Lavie C, Ventura, HO. Vasodilating versus first generation beta blockade for the treatment of cardiovascular conditions. Postgrad Med. 2012; 124(2).

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutics in Metabolic Diseases;Advances in Experimental Medicine and Biology;2022-12-02

2. Effect of Third-Generation Beta Blockers on Weight Loss in a Population of Overweight-Obese Subjects in a Controlled Dietary Regimen;Journal of Nutrition and Metabolism;2021-09-23

3. Drugs Interfering with Insulin Resistance and Their Influence on the Associated Hypermetabolic State in Severe Burns: A Narrative Review;International Journal of Molecular Sciences;2021-09-10

4. Acute glycaemic management before, during and after exercise for cardiac rehabilitation participants with diabetes mellitus: a joint statement of the British and Canadian Associations of Cardiovascular Prevention and Rehabilitation, the International Council for Cardiovascular Prevention and Rehabilitation and the British Association of Sport and Exercise Sciences;British Journal of Sports Medicine;2020-12-23

5. Obesity-Hypertension Physiopathology and Treatment: A Forty-Year Retrospect;Updates in Hypertension and Cardiovascular Protection;2018-12-07